{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T18:19:50Z","timestamp":1769969990703,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2020-01730"],"award-info":[{"award-number":["2020-01730"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2020-02129"],"award-info":[{"award-number":["2020-02129"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","award":["FoUI-953887"],"award-info":[{"award-number":["FoUI-953887"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","award":["FoUI-955284"],"award-info":[{"award-number":["FoUI-955284"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.drup.2023.100955","type":"journal-article","created":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T17:06:20Z","timestamp":1677949580000},"page":"100955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Synergistic antiviral activity against drug-resistant HIV-1 by naturally occurring dipeptide and A single-stranded oligonucleotide"],"prefix":"10.1016","volume":"68","author":[{"given":"Rafael","family":"Ce\u00f1a-Diez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Lena","family":"Spetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"S\u00f6nnerborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2023.100955_bib1","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s40121-022-00626-8","article-title":"Novel naturally occurring dipeptides and single-stranded oligonucleotide act as entry inhibitors and exhibit a strong synergistic anti-HIV-1 profile","volume":"11","author":"Cena-Diez","year":"2022","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.drup.2023.100955_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzym. Regul."},{"key":"10.1016\/j.drup.2023.100955_bib3","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/QAD.0000000000002883","article-title":"Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis","volume":"35","author":"Cutrell","year":"2021","journal-title":"AIDS"},{"key":"10.1016\/j.drup.2023.100955_bib4","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1097\/QAD.0000000000003326","article-title":"High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for INSTI salvage therapy","volume":"36","author":"Duarte","year":"2022","journal-title":"AIDS"},{"key":"10.1016\/j.drup.2023.100955_bib5","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1093\/jac\/dkz256","article-title":"A systematic review of the genetic mechanisms of dolutegravir resistance","volume":"74","author":"Rhee","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drup.2023.100955_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105427","article-title":"Genotypic correlates of resistance to the HIV-1 strand transfer integrase inhibitor cabotegravir","volume":"208","author":"Rhee","year":"2022","journal-title":"Antivir. Res."},{"key":"10.1016\/j.drup.2023.100955_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01717-19","article-title":"Comparable in vitro activities of second-generation HIV-1 integrase strand transfer inhibitors (INSTIs) on HIV-1 clinical isolates with INSTI resistance mutations","volume":"64","author":"Saladini","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2023.100955_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00479-21","article-title":"Fecal metabolome signature in the HIV-1 elite control phenotype: enrichment of dipeptides acts as an HIV-1 antagonist but a prevotella agonist","volume":"95","author":"Sperk","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.drup.2023.100955_bib9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1128\/AAC.03909-14","article-title":"Antiviral characteristics of GSK1265744, an HIV integrase inhibitor dosed orally or by long-acting injection","volume":"59","author":"Yoshinaga","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2023.100955_bib10","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/infdis\/jiy428","article-title":"Accumulation of multiple mutations in vivo confers cross-resistance to new and existing integrase inhibitors","volume":"218","author":"Zhang","year":"2018","journal-title":"J. Infect. Dis."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764623000389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764623000389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:00:39Z","timestamp":1761282039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764623000389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":10,"alternative-id":["S1368764623000389"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2023.100955","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic antiviral activity against drug-resistant HIV-1 by naturally occurring dipeptide and A single-stranded oligonucleotide","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2023.100955","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100955"}}